We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Antitrust Law: Pharmaceutical Industry

24 March 2008

The National Law Journal
During the past several years, there has been an increase in antitrust enforcement directed at the pharmaceutical industry, both in the United States and in Europe, primarily focused on conduct by branded pharmaceutical companies that might affect the timing and effectiveness of entry by less costly generic drugs. The use of novel antitrust theories and tactics as a method of policing this market is a notable recent development.


Loading data